IMP
Process View
negative regulation of striated muscle cell differentiation
Any process that stops, prevents, or reduces the frequency, rate or extent of striated muscle cell differentiation.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of striated muscle cell differentiation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CEACAM6 | carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | 1.000 | Human | |
| CEACAM5 | carcinoembryonic antigen-related cell adhesion molecule 5 | 0.999 | ||
| CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 0.998 | Human | |
| CEACAM7 | carcinoembryonic antigen-related cell adhesion molecule 7 | 0.964 | Human | |
| HDAC4 | histone deacetylase 4 | 0.854 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.768 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.593 | ||
| TBX5 | T-box 5 | 0.561 | ||
| MEF2C | myocyte enhancer factor 2C | 0.487 | ||
| PSG4 | pregnancy specific beta-1-glycoprotein 4 | 0.382 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.282 | ||
| JAG1 | jagged 1 | 0.218 | ||
| PSG9 | pregnancy specific beta-1-glycoprotein 9 | 0.217 | Human | |
| PRKD2 | protein kinase D2 | 0.200 | ||
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.166 | ||
| PSG6 | pregnancy specific beta-1-glycoprotein 6 | 0.152 | Human | |
| FAS | Fas (TNF receptor superfamily, member 6) | 0.143 | ||
| PSG5 | pregnancy specific beta-1-glycoprotein 5 | 0.132 | Human | |
| PML | promyelocytic leukemia | 0.132 | ||
| PSG3 | pregnancy specific beta-1-glycoprotein 3 | 0.125 | ||
| MEF2A | myocyte enhancer factor 2A | 0.099 | ||
| FSTL1 | follistatin-like 1 | 0.079 | ||
| SRF | serum response factor (c-fos serum response element-binding transcription factor) | 0.077 | ||
| DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | 0.075 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.069 | ||
| PSG1 | pregnancy specific beta-1-glycoprotein 1 | 0.062 | ||
| NOTCH3 | notch 3 | 0.050 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.040 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.037 | ||
| PAX8 | paired box 8 | 0.033 | ||
| RASSF1 | Ras association (RalGDS/AF-6) domain family member 1 | 0.032 | ||
| CEACAM8 | carcinoembryonic antigen-related cell adhesion molecule 8 | 0.031 | Human | |
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.026 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.025 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.020 | ||
| HDAC7 | histone deacetylase 7 | 0.020 | Human | |
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.020 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.019 | ||
| FOXP3 | forkhead box P3 | 0.019 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.018 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.018 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.018 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.017 | ||
| MAML1 | mastermind-like 1 (Drosophila) | 0.016 | ||
| GATA4 | GATA binding protein 4 | 0.016 | ||
| SUZ12 | suppressor of zeste 12 homolog (Drosophila) | 0.016 | ||
| EED | embryonic ectoderm development | 0.014 | ||
| PSG2 | pregnancy specific beta-1-glycoprotein 2 | 0.013 | ||
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.013 | ||
| DEAF1 | deformed epidermal autoregulatory factor 1 (Drosophila) | 0.012 | ||
| NOG | noggin | 0.012 | ||
| EWSR1 | Ewing sarcoma breakpoint region 1 | 0.012 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.011 | ||
| MSX2 | msh homeobox 2 | 0.010 | ||
| CARTPT | CART prepropeptide | 0.010 |